Factors affecting mortality rate due to neoplasms and circulatory diseases during the 2019-2020 in the Russian Federation
In the Russian Federation in 2020, during the COVID-19 pandemic, compared with 2019, there was a significant increase in mortality from all causes (+19%, or 340 thousand people), and only half of these additional deaths were associated with a new coronavirus infection. Mortality from cardiovascular diseases (CVD), the main cause of death in the country, increased significantly (by 12%) (44% in the structure of all deaths in 2020). At the same time, over the specified period, mortality from neoplasms decreased by almost 1% (14% in the structure of total mortality in 2020).
A study of the factors that could affect these differences showed that the decrease in mortality from cancer was due to a noticeable increase in the financing of medical care in the oncology profile in inpatient conditions (+18% at constant prices in 2020) against the background of only a slight decrease in its volume (-4%), as well as due to an increase in the volume of care for this pathology in day hospitals (+13%). All this happened against the background of the allocation of additional funding for the fight against cancer and strict control over the implementation of targets in this area by the federal government bodies (Ministry of Health of the Russia) and the Mandatory Medical Insurance Fund. However, in the profile of "Oncohematology" in the Russian Federation (excluding Moscow), there was a decrease in the volume of medical care (-15.5%), and their financial support (-6.5%), which, most likely, led to an increase in mortality from this pathology (+2%).
Against the background of a decrease in mortality from all neoplasms in 2020 compared to 2019, there was an increase in deaths from oncohematological pathology by 2%, which is due to the absence of an increase in the volume of care in this profile in inpatient conditions (a decrease by 0.5% in constant 2020 prices) and insufficient increase in funding for these volumes (+12.8%) compared to the overall growth in funding for the "Oncology" profile (+18%).
And for the class CVD, and for neoplasms there was a significant decrease in primary morbidity (by 16-17%), which can have an extremely negative effect on the early detection and timely treatment of these diseases in the coming years. The authors conclude that in order to reduce mortality in the Russian Federation, it is necessary to increase both the volume of medical care and the costs of its provision.
Keywords:COVID-19 pandemic, mortality from neoplasms, mortality from diseases of the circulatory system, volume of aid on the profile "Oncology", the amount of help on the profile "Oncohematology", financial costs on the profile "Oncology", financial costs on the profile "Oncohematology", the amount of help on the profile "Cardiology", financial costs on the profile "Cardiology "
Funding. The study had no sponsor support.
Conflict of interest. The authors declare no conflict of interest.
Contribution. Scientific leadership of the study, concept and design of the study, analysis of results, writing and editing of text - Ulumbekova G.E.; collection and processing of material, statistical data processing, writing and editing of text - Ginoyan A.B.; material processing, writing and editing of text - Petrachkov I.V.
For citation: Ulumbekova G.E., Ginoyan A.B., Petrachkov I.V. Factors affecting mortality rate due to neoplasms and circulatory diseases during the 2019-2020 in the Russian Federation. ORGZDRAV: novosti, mneniya, obuchenie. Vestnik VSHOUZ [HEALTHCARE MANAGEMENT: News, Views, Education. Bulletin of VSHOUZ]. 2021; 7 (3): 4-23. DOI: https://doi.org/10.33029/2411-8621-2021-7-3-4-23 (in Russian)
1. Ahmad F.B., Anderson R.N. The Leading Causes of Death in the US for 2020. JAMA. 2021; 325 (18): 1829–30. DOI: https://doi.org/10.1001/jama.2021.5469.
2. Decree of the President of the Russian Federation dated July 21, 2020 No. 474 «On the national development goals of the Russian Federation for the period up to 2030». (in Russian)
3. Ulumbekova G.E., Ginoyan A.B., Prokhorenko N.F., Kalashnikova A.V. A systematic approach to achieving the national goal of increasing life expectancy to 78 years by 2024. Ekonomika. Nalogi. Pravo [Economics. Taxes. Right]. 2019; 12 (2): 19–30. (in Russian)
4. Ulumbekova G.E. Healthcare of Russia. What to do. Status and offers: 2019–2024. 3rd ed. Moscow: GEOTARMedia, 2019: 416 p. (in Russian)
5. Aganbegyan A.G. Oncological diseases - the main threat to human life in the future. ORGZDRAV: novosti, mneniya, obuchenie. Vestnik VShOUZ [ORGZDRAV: News, Opinions, Training. Bulletin of VSHOUZ]. 2019; 5 (4): 43-54. DOI: https://doi.org/10.24411/2411-8621-2019-14003 (in Russian)
6. Report on the results of the activities of the Federal Mandatory Medical Insurance Fund in 2020. June 29, 2021. Protocol No. 2, issue II. (in Russian)
7. National leadership. Organization of health care and public health. In: G.E. Ulumbekova, V.A. Medic (eds). Moscow: GEOTAR-Media, 2022. (in print) (in Russian)